Related references
Note: Only part of the references are listed.The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation
Dennis A. Hesselink et al.
CLINICAL PHARMACOKINETICS (2014)
Tacrolimus Trough Level at Discharge Predicts Acute Rejection in Moderately Sensitized Renal Transplant Recipients
Katelyn R. Richards et al.
TRANSPLANTATION (2014)
OPTN/SRTR 2011 Annual Data Report: Kidney
A. J. Matas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized-Controlled Clinical Trials
R. Bouamar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Influence of African-American Ethnicity on Acute Rejection after Early Steroid Withdrawal in Primary Kidney Transplant Recipients
A. Padiyar et al.
TRANSPLANTATION PROCEEDINGS (2010)
African American Kidney Transplantation Survival The Ability of Immunosuppression to Balance the Inherent Pre- and Post-Transplant Risk Factors
Gregory E. Malat et al.
DRUGS (2009)
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference
Pierre Wallemacq et al.
THERAPEUTIC DRUG MONITORING (2009)
Trough Tacrolimus Concentrations in the First Week After Kidney Transplantation Are Related to Acute Rejection
Alberto M. Borobia et al.
THERAPEUTIC DRUG MONITORING (2009)
Potential Differences in Kidney Allograft Outcomes Between Ethnicities When Converting to Sirolimus Base Immunosuppression
N. Patel et al.
TRANSPLANTATION PROCEEDINGS (2009)
The role of ethnicity in variability in response to drugs: Focus on clinical pharmacology studies
S. U. Yasuda et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype
Iain A. M. MacPhee et al.
TRANSPLANTATION (2008)
Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation
M. Naesens et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Tacrolimus dose in black renal transplant recipients
Nidyanandh Vadivel et al.
TRANSPLANTATION (2007)
CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates:: Guidelines from an experimental study
V. Haufroid et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome
DRJ Kuypers
TRANSPLANT INTERNATIONAL (2005)
Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation
A Lo et al.
CLINICAL TRANSPLANTATION (2004)
Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus
DE Hricik et al.
TRANSPLANTATION (2003)
Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus
DA Hesselink et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Combined analysis of cytokine genotype polymorphism and the level of expression with allograft function in African-American renal transplant patients
DO McDaniel et al.
TRANSPLANT IMMUNOLOGY (2003)
HLA matching and the united network for organ sharing allocation system: Impact of HLA matching on African-American recipients of cadaveric kidney transplants
LM Rebellato et al.
TRANSPLANTATION (2002)
Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation
C Staatz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
Increased costimulatory responses in African-American kidney allograft recipients
A Hutchings et al.
TRANSPLANTATION (2001)
The pharmacokinetics and metabolic disposition of tacrolimus: A comparison across ethnic groups
LM Mancinelli et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Share Paper
